Cancer Clinical Trial 20203532

[LCID Study Number: 20203532]

Collection of Biologic Samples and Clinical Data from Subjects with a Familial Risk that Predispose to Pancreatic Cancer

The purpose of this study is to create a comprehensive pancreatic ductal adenocarcinoma (PDAC) bio-specimen bank for testing of circulating early detection markers.

Disease/Condition: Cancer

Department: Hematology and Oncology

Location(s): Lahey Hospital & Medical Center (Burlington)

Primary Contact Email: [email protected]

Primary Contact Phone: 781-744-3421

Protocol #: 20203532
Principal Investigator(s): Lata Thatai
Trial Phase: Investigator Initiated Study Observational